71 episodes

News and views from the world of clinical oncology and hematology.

The ASCO Post Podcast Harborside

    • Science

News and views from the world of clinical oncology and hematology.

    Recent FDA Approvals in Leukemia and Lymphoma

    Recent FDA Approvals in Leukemia and Lymphoma

    This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
    Coverage of stories discussed this week on ascopost.com:
    FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
    FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
    To listen to more podcasts from ASCO, visit asco.org/podcasts.

    • 15 min
    First-Line Atezolizumab vs Chemotherapy for PD-L1–Positive Metastatic NSCLC

    First-Line Atezolizumab vs Chemotherapy for PD-L1–Positive Metastatic NSCLC

    This week, we’ll review results of a trial that evaluated first-line anti–PD-L1 therapy vs platinum-based chemotherapy in patients with metastatic lung cancer and high PD-L1 expression. We’ll also discuss findings from a study that evaluated whether patients receiving care for advanced cancer based on the recommendations of a molecular tumor board tended to survive longer or experience more time without disease progression.
    Coverage of stories discussed this week on ascopost.com:
    First-Line Atezolizumab vs Chemotherapy in PD-L1–Positive Metastatic NSCLC: IMpower110
    Cancer Therapy Based on Molecular Tumor Board Recommendations: Improvement in Outcomes?
    To listen to more podcasts from ASCO, visit asco.org/podcasts.

    • 12 min
    Breast Cancer News From the ESMO Virtual Congress 2020

    Breast Cancer News From the ESMO Virtual Congress 2020

    This week, we’ll be featuring our last disease-specific roundup from the ESMO Virtual Congress 2020. We’ll hear from three experts on their findings in breast cancer, focusing on results from two IMpassion trials as well as the efficacy of a novel antibody-drug conjugate in triple-negative disease, and a telehealth program for patients receiving chemotherapy.
    To listen to more podcasts from ASCO, visit asco.org/podcasts.

    • 15 min
    Lung Cancer Reports From the ESMO Virtual Congress 2020

    Lung Cancer Reports From the ESMO Virtual Congress 2020

    This week, we’ll be reviewing results from several reports on lung cancer presented during the ESMO Virtual Congress 2020. The findings focus on the use of radiotherapy, biomarkers, targeted treatments, and immunotherapy.
    To listen to more podcasts from ASCO, visit asco.org/podcasts.

    • 12 min
    ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

    ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

    This week, we’re hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We’ll hear directly from the researchers about first-line treatment for metastatic renal cell carcinoma, as well as the long-term results of a doublet therapy for men with advanced hormone-naive prostate cancer.
    To listen to more podcasts from ASCO, visit asco.org/podcasts.

    • 13 min
    ESMO Virtual Congress 2020: Findings in Breast and Head and Neck Cancers

    ESMO Virtual Congress 2020: Findings in Breast and Head and Neck Cancers

    This weekend, the ESMO Virtual Congress 2020 is underway, and we’re sharing interviews with two authors of high-impact papers on breast cancer and head and neck cancer presented at the event.
    To listen to more podcasts from ASCO, visit asco.org/podcasts.

    • 10 min

Top Podcasts In Science

Listeners Also Subscribed To